We are live on
!
Find out more
QCM
Quantinno Capital Management Portfolio holdings
AUM
$83.3B
1-Year Est. Return
37.97%
This Fund
S&P 500
This Quarter
Est. Return
+22.01%
1 Year Est. Return
+37.97%
3 Year Est. Return
+119.21%
5 Year Est. Return
+172.12%
10 Year Est. Return
–
AUM
$83.3B
AUM Growth
+$23.4B
(+39%)
Cap. Flow
+$14.4B
Cap. Flow
% of AUM
17.33%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
3,531
New
234
Increased
2,563
Reduced
581
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$792M |
| 2 |
Apple
AAPL
|
+$635M |
| 3 |
Amazon
AMZN
|
+$353M |
| 4 |
Microsoft
MSFT
|
+$275M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$77M |
| 2 |
Comcast
CMCSA
|
+$55.9M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$53M |
| 4 |
HOLX
Hologic
HOLX
|
+$43.9M |
| 5 |
A.O. Smith
AOS
|
+$38.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Financials | 12.42% |
| 3 | Industrials | 10.68% |
| 4 | Consumer Discretionary | 9.94% |
| 5 | Healthcare | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Acumen Pharmaceuticals
ABOS
$192M
| $71.5K | ﹤0.01% |
+26,769
| New | +$66.1K |
|
3402
Iovance Biotherapeutics
IOVA
$4.39B
| $70.7K | ﹤0.01% |
+17,000
| New | +$64.6K |
|
3403
MiMedx Group
MDXG
$689M
| $70.5K | ﹤0.01% |
18,320
-48,100
| -72% | -$176K |
|
3404
Annexon
ANNX
$741M
| $70K | ﹤0.01% |
+12,263
| New | +$67.8K |
|
3405
TechTarget
TTGT
$276M
| $69.5K | ﹤0.01% |
+19,305
| New | +$88.5K |
|
3406
Aspen Aerogels
ASPN
$412M
| $65.5K | ﹤0.01% |
+10,334
| New | +$50.7K |
|
3407
1-800-Flowers.com
FLWS
$177M
| $65K | ﹤0.01% |
+18,682
| New | +$73.7K |
|
3408
Veru
VERU
$39.7M
| $62.6K | ﹤0.01% |
20,000
| – | – |
|
3409
Sana Biotechnology
SANA
$898M
| $56.1K | ﹤0.01% |
16,083
-2,950
| -15% | -$9.5K |
|
3410
Energy Vault
NRGV
$700M
| $55.7K | ﹤0.01% |
11,828
| – | – |
|
3411
Opendoor
OPEN
$2.51B
| $54K | ﹤0.01% |
+11,692
| New | +$56K |
|
3412
N-able
NABL
$737M
| $52.7K | ﹤0.01% |
14,350
-127,630
| -90% | -$531K |
|
3413
Bumble
BMBL
$396M
| $51.9K | ﹤0.01% |
+16,209
| New | +$55.4K |
|
|
ELME
3414
Elme Communities
ELME
$146M
| $50.4K | ﹤0.01% |
34,075
-6,049
| -15% | -$12.3K |
|
|
OKYO
3415
OKYO Pharma
OKYO
$68.2M
| $49.9K | ﹤0.01% |
+33,255
| New | +$53.3K |
|
3416
TMC The Metals Company
TMC
$1.59B
| $47.8K | ﹤0.01% |
+10,780
| New | +$56.2K |
|
|
SFIX
3417
Stitch Fix
SFIX
$387M
| $47.3K | ﹤0.01% |
+11,511
| New | +$41.9K |
|
|
NXDR
3418
Nextdoor Holdings
NXDR
$944M
| $45.2K | ﹤0.01% |
19,923
-10,814
| -35% | -$20.2K |
|
|
VZLA
3419
Vizsla Silver
VZLA
$1.29B
| $44.2K | ﹤0.01% |
13,387
| – | – |
|
3420
Cabaletta Bio
CABA
$427M
| $40.1K | ﹤0.01% |
+12,905
| New | +$42.4K |
|
3421
Amplify Energy
AMPY
$190M
| $40.1K | ﹤0.01% |
+10,084
| New | +$51.8K |
|
|
AZIO
3422
Azio AI Holdings
AZIO
$19.8M
| $38.4K | ﹤0.01% |
22,574
| – | – |
|
|
ONL
3423
Orion Office REIT
ONL
$139M
| $35.9K | ﹤0.01% |
12,423
| – | – |
|
3424
Anavex Life Sciences
AVXL
$216M
| $33K | ﹤0.01% |
12,733
-41,814
| -77% | -$124K |
|
3425
SmartRent
SMRT
$222M
| $29K | ﹤0.01% |
+24,335
| New | +$30.9K |
|
Similar funds
CBU
Quantinno Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Quantinno Capital Management held 3,531 positions worth $83.3B, up 39% from $59.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Quantinno Capital Management deployed $14.4B of net new capital in Q2 2026, opening 234 new positions and adding to 2,563 existing holdings. Its largest new stake was Honeywell Aerospace: 222,049 shares worth $49.1M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Ingredion, an estimated $77M trimmed.
- Quantinno Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 222,049 shares worth $49.1M.
- Quantinno Capital Management added most to NVIDIA in Q2 2026, an estimated $792M increase.
- Quantinno Capital Management's biggest Q2 2026 reduction was Ingredion, cutting an estimated $77M.
- Quantinno Capital Management fully exited Hologic in Q2 2026, selling an estimated $43.9M.
- Quantinno Capital Management's ten largest holdings make up 22% of its $83.3B portfolio in Q2 2026.
- Quantinno Capital Management opened 234 new positions and closed 97 in Q2 2026.
- Quantinno Capital Management's portfolio value rose 39% quarter-over-quarter to $83.3B.
Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.